Dr. Tanasijevic

	Department of Pathology
	Brigham and Women's Hospital
	A teaching Affliate of Harvard Medical School
Home About Us Services Research Education Staff For Patient For Medical Professional Alumni Anatomic Pathology Clinical Laboratories Blood Bank Cytogenetics About Our Research CMOP Histopathology Core Virtual Specimen Locator Biospecimen banking Vascular Research Division DGAP Project Center for Uterine Fibroids Residency AP Program CP program Fellowships CME Faculty Residents and Fellows Administration Patient Resources Referral Information Useful Links Referral Information Calendar and Events Education and Training Sign Out Forms Surg Path Manual Powerpath instructions Useful Links

Name and Present Position:

MILENKO J.TANASIJEVIC, Director of Clinical Laboratories Division, Department of Pathology

Address:

Brigham and Women's Hospital, Department of Pathology, 75 Francis Street, Amory 215, Boston, MA, 02115

Medical School (including school name, date and degree awarded):

1987 MD, Medical School at the University Cyril and Methodius, Skopje, Macedonia

Graduate Medical Education (including dates and institution of internships, residencies, fellowships, etc.):

1993 Chief Resident in Clinical Pathology, Brigham and Women's Hospital
1990-93 Resident in Clinical Pathology, Brigham and Women's Hospital
1988-90 Clinical Research Fellowship, Fetal Lung Maturity Laboratory, Brigham and Women's Hospital

Certification:

1993 American Board of Pathology (Clinical Pathology)
1992 Massachusetts Board of Registration in Medicine

Current Academic Appointment:

Associate Professor of Pathology, Harvard Medical School, Boston, MA

Current Medical Staff Appointment(s):

Director of Clinical Laboratories Division, Brigham and Women's Hospital
Director of Clinical Laboratories, Dana-Farber Cancer Institute, Boston, MA

Selected Bibliography:

Tanasijevic MJ, Cannon C. Evaluation of Coronary Artery Patency Using Cardiac Markers. In press: Journal of Thrombosis and Thrombolysis 2005; 19:21-24
McElrath TF, Colon I, Hecht J, Tanasijevic MJ, Norwitz ER. Neonatal respiratory distress syndrome as a function of gestational age and an assay for surfactant-to-albumin ratio. OB GYN 2004; 103(3):463-8.
Sabatine M, Morrow DA, deLemos JA, Omland T, Desani MY, Tanasijevic MJ, Hall C, McCabe CH, Braunwald E. Acute Changes in Circulating Natriuretic Peptide Levels in Relation to Myocardial Ischemia. JACC 2004; 44(10):1988-1995.
Srinivas VS, Cannon CP, Gibson M, Antman EM, Greenberg MA, Tanasijevic MJ, Murphy S, de Lemos JA, Sokol S, Braunwald E and Miller HS. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality following thrombolysis in acute myocardial infarction: a TIMI 10B substudy. American Heart Journal 2001; 142:29-36.
de Lemos JA, Morrow DA, Gibson CM, Murphy SA, Rifai N, Tanasijevic M, Giugliano RP, Schuhwerk KC, McCabe CH, Cannon CP, Antman EM and Braunwald E, for the TIMI 14 Investigators. Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy. Am J Cardio 2001; 88:353-358.
Morrow DA, Rifai N, Tanasijevic MJ, Wybenga DR, De Lemos JA, Antman E. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: A thrombolysis in myocardial infarction (TIMI) 11B Substudy. Clin Chem 2000; 46(4):453-460.
Morrow DA, Antman EM, Tanasijevic M, Rifai N, deLemos JA, McCabe CH, Cannon CP, Braunwald E. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: A TIMI 11B substudy. JACC 2000; 36:1812-7.
Delgado JC, Green MF, Winkelman JW, Tanasijevic MJ. Comparison of disaturated phosphatidylcholine and FLM S/A ratio in diabetic and nondiabetic pregnancies. Am J Clin Path 2000; 113:233-239.
Tanasijevic MJ, Cannon CP, Antman EM, Wybenga DR, Fischer GA, Grudzien C, Gibson CM, Winkelman JW, Braunwald E. Myoglobin, creatin-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction. Results from the thrombolysis in myocardial infarction study TIMI 10B. J Am Coll Cardio 1999; 34:739-747.
Tanasijevic MJ, Cannon CP, Wybenga D, Fischer G, Grudzien C, McCabe CH, Gibson M, Fischer G, Wybenga D, Antman EM, Braunwald E. Cardiac troponin I, myoglobin and CK-MB for non-invasive assessment of reperfusion after thrombolytic therapy for acute myocardial infarction. Am Heart J 1997; 134:622-630.